authors
- Sandhu, S
- Hill, A
- Gan, H
- Friedlander, M
- Voskoboynik, M
- Barlow, P
- Townsend, A
- Song, J
- Zhang, Y
- Liang, L
- Desai, J
Tislelizumab, an anti-PD-1 antibody, in patients with urothelial carcinoma (UC): Results from an ongoing phase I/II study
Conference Paper
- Overview
- Additional Document Info
- View All
Overview
publication date
- December 1, 2018
has subject area
- Oncology & Carcinogenesis (Science Metrix)
published in
- Annals of Oncology Journal
presented at event
- ESMO Immuno-Oncology Congress Conference